ISR
Sign in
ISR Immune System Regulation Holding AB (publ)
Save
96.61M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden.
Similar securities
Based on sector and market capitalization
Report issue